Spiro-isoxazolidine derivatives as cholinergic agents

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 498/10 (2006.01) A61K 31/435 (2006.01) C07D 498/20 (2006.01)

Patent

CA 2087529

2087529 9201690 PCTABS00010 Compounds of general formula (I), wherein: A represents (CH2)m optionally substituted by R3, B represents (CH2)n optionally substituted by R4, R1 represents hydrogen, C1-C6 alkyl, C3-6 alkenyl or C3-6 alkynyl, R2 represents hydrogen, C1-6 alkyl or COOR5, in which R5 represents C1-C6 alkyl, R3 and R4 independently represent hydrogen or C1-C6 alkyl, n and m independently represent an integer from 1-3 inclusive, Y represents O or S, provided that, any two of R2, R3 and R4 may together form a C1-3 alkylene chain, and pharmaceutically acceptable derivatives thereof are useful as pharmaceuticals, in particular as central muscarinic acetylcholine receptor agonists. The compounds are therefore useful in the treatment of neurological disorders such as presenile and senile dementia, Huntington's chorea, tardive dyskinesia, hyperkinesia, mania and Tourette Syndrome.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Spiro-isoxazolidine derivatives as cholinergic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Spiro-isoxazolidine derivatives as cholinergic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Spiro-isoxazolidine derivatives as cholinergic agents will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2025846

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.